China · Findings · Subsidiary of a US issuer (Exhibit 21)
GEHC · Ex21
Why it is here
Indicator “Subsidiary of a US issuer (Exhibit 21)” computed from public data: GEHC · Ex21 — buyer 浙江大学医学院附属第二医院.
Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.
Details
- Company / subject
- GEHC · Ex21
- Buyer
- 浙江大学医学院附属第二医院
- Indicator
- Subsidiary of a US issuer (Exhibit 21)
- Records behind the indicator
- 3
- Found
- 4 October 2026
- Code
- CN-12397
- Reference
- 2026-02-04
- Reference
- 0001932393-26-000007
Other records of this company86
- 017 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 027 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 036 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 046 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 055 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 065 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 075 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 085 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 095 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 104 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
All 86
- 114 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 124 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 134 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 144 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 154 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 164 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 174 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 184 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 194 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 204 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 214 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 224 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 234 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 244 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 254 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 264 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 274 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 284 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 294 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 304 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 314 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 324 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 334 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 344 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 354 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 364 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 374 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 384 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 394 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 404 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 414 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 424 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 434 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 444 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 454 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 464 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 474 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 484 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 494 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 504 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 514 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 524 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 534 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 544 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 554 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 564 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 574 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 584 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 594 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 604 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 614 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 624 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 634 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 644 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 654 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 664 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 674 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 684 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 694 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 704 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 714 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 724 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 734 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 744 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 754 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 764 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 774 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 784 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 794 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 804 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 814 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 824 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 834 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 844 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 854 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
- 864 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)